The value of blood measurements, ultrasound an muscle electric studies to fortell the outcome of low back pain and sciatic pain and to evaluate the effect of the muscle relaxant tolperiso

Phase 1

• Conditions: Acute low back pain with or withour radicular signs; Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

• Registration Number: EUCTR2019-001885-14-HU
• Lead Sponsor: ational Research, Development and Innovation Office

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-29
• Last Update Posted: 25 November 2019

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

Patients aged 18-80 years with acute (less than 1-month) low back pain with or without radicular signs, who do not have severe diseases (abscess, tumor etc) in the background, had CT or MRI scan, and who has given written consent to participte in the study.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 100
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 50

Exclusion Criteria

Pregnancy, hypesensitivity to tolperisone in the history, severe liver or kidney disease, other severe diseases (abscess, tumor etc) in the background of pain.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified